Key publication
930
Therapeutic Areas
Methods & challenges

Key publication

Proof of Pharmacology, Safety, and Pharmacokinetics of the Novel TRPA1 Antagonist BI 1839100: A Randomized, Placebo-Controlled, Parallel Group, First-In-Human Study in Healthy Male Participants.

Key publication

Mild psoriasis as a suitable model for proof-of-mechanism in a phase 1B setting: Results from a double-blind placebo-controlled trial with guselkumab.

Key publication

Sodium Oxybate as a Potential New Treatment for Catatonia in Patients With Depression, Bipolar Disorder, or a Psychotic Disorder: Protocol for a Randomized Controlled Trial.

Key publication

Profiling a Neo-Antigen-Driven Immune Response in Healthy Volunteers: A Randomized, Double-Blind, Placebo-Controlled Study of the KLH Challenge Model.

Key publication

A systematic review of pharmaceutical targets in the mucosal immune system for treatment of non-intestinal auto-immune diseases.

2 July 2025

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Read Publication

Key publication

EUROPEAN ASSOCIATION OF PERINATAL MEDICINE Position statement: environmental sustainability in obstetric healthcare.

2 July 2025

European journal of obstetrics, gynecology, and reproductive biology

Read Publication

Key publication

Preclinical evaluation of glycan-targeting monoclonal antibodies for bimodal near-infrared fluorescence and photoacoustic imaging of gastrointestinal cancers.

Key publication

Spectrum and Impact of Reported Side Effects of Omalizumab in Patients With Chronic Urticaria: A Long-Term Multicentre Real-World Study.

2 June 2025

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology

Read Publication

Key publication

Parameters linked with higher Itch Severity in Chronic Spontaneous Urticaria - CURE Results.

28 May 2025

The journal of allergy and clinical immunology. In practice

Read Publication